Reactivity patterns and epitope specificities of anti-Cryptococcus neoformans monoclonal antibodies by enzyme-linked immunosorbent assay and dot enzyme assay.
about
Cryptococcus neoformans: historical curiosity to modern pathogenCas3p belongs to a seven-member family of capsule structure designer proteins.Ctr2 links copper homeostasis to polysaccharide capsule formation and phagocytosis inhibition in the human fungal pathogen Cryptococcus neoformans.Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies.Characterization of anticapsular monoclonal antibodies that regulate activation of the complement system by the Cryptococcus neoformans capsuleBivalency is required for anticapsular monoclonal antibodies to optimally suppress activation of the alternative complement pathway by the Cryptococcus neoformans capsule.How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans.The different binding patterns of two immunoglobulin M monoclonal antibodies to Cryptococcus neoformans serotype A and D strains correlate with serotype classification and differences in functional assays.Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural networkMolecular and idiotypic analyses of the antibody response to Cryptococcus neoformans glucuronoxylomannan-protein conjugate vaccine in autoimmune and nonautoimmune miceFc-dependent and Fc-independent opsonization of Cryptococcus neoformans by anticapsular monoclonal antibodies: importance of epitope specificityContribution of epitope specificity to the binding of monoclonal antibodies to the capsule of Cryptococcus neoformans and the soluble form of its major polysaccharide, glucuronoxylomannan.Monoclonal antibodies specific for immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, reduce serotype bias in an immunoassay for cryptococcal antigenNew technology and resources for cryptococcal researchMonoclonal antibodies reactive with immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformansLarge-scale evaluation of the immuno-mycologics lateral flow and enzyme-linked immunoassays for detection of cryptococcal antigen in serum and cerebrospinal fluidAllergen1 regulates polysaccharide structure in Cryptococcus neoformans.Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus neoformansThe capsule of the fungal pathogen Cryptococcus neoformans.Phenotypic heterogeneity in expression of epitopes in the Cryptococcus neoformans capsuleAntigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains.UDP-Glucuronic Acid Transport Is Required for Virulence of Cryptococcus neoformans.
P2860
Q27025924-D15D60BF-4520-42BA-BAA5-5510842EEAEFQ33560210-8528B7CC-3B2C-43E2-9B2C-DFC9E9442AD2Q33686884-0B9674D4-0E62-41FF-9B5D-7BAECF627910Q33693515-C938D20D-4657-4DFB-BF75-C8337F3B3554Q33752366-EE91318B-456F-447D-B173-DC88CC392129Q33752377-B2C9F46E-C843-4419-8657-40A0ECC9CC6AQ33894565-6C5078AF-4769-4C10-9661-248773B8DE66Q33991158-EDB3B79E-1EFE-479E-9833-5206FF9293D8Q33991281-FA27AC15-B986-490F-B3FA-B03B99ED065AQ34001701-F8D1B996-4EF3-41F2-B236-562341B865D3Q34123230-85EB59B0-0FDB-44A8-8EA3-0B2F61F9AB68Q34779166-65B071C6-EF57-46EF-9FFA-E2448730F6C5Q35138768-511387F7-E72C-4952-8D2E-0622A1219BEFQ35611515-CCB1FC9E-EDA9-4A6E-86BB-19D07951C966Q35923662-6A8F08C8-1F6E-4BC5-9431-4BCCB573505EQ36504837-04C7C585-0C3F-40D6-878F-AAD0EA7D81C3Q36950154-4D9291CE-18A3-4A94-BFF2-CAD5914C564DQ37066510-CF5AC803-FE5F-42F4-8A3B-93E174CA1A5AQ37337879-9A001C1C-4439-45DF-8995-85225AC21260Q37459771-4A81E07E-3546-4F23-BE1C-857C4436CA78Q39746326-352D1D8D-07EE-41B2-A2F7-6C859DA257C0Q47830888-081D0295-84DA-4013-B31D-02BCEC007B02
P2860
Reactivity patterns and epitope specificities of anti-Cryptococcus neoformans monoclonal antibodies by enzyme-linked immunosorbent assay and dot enzyme assay.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Reactivity patterns and epitop ...... nt assay and dot enzyme assay.
@ast
Reactivity patterns and epitop ...... nt assay and dot enzyme assay.
@en
type
label
Reactivity patterns and epitop ...... nt assay and dot enzyme assay.
@ast
Reactivity patterns and epitop ...... nt assay and dot enzyme assay.
@en
prefLabel
Reactivity patterns and epitop ...... nt assay and dot enzyme assay.
@ast
Reactivity patterns and epitop ...... nt assay and dot enzyme assay.
@en
P2093
P2860
P1476
Reactivity patterns and epitop ...... ent assay and dot enzyme assay
@en
P2093
P2860
P304
P407
P577
1997-02-01T00:00:00Z